Skip to content

Haemonetics HAE Other income, net (Note 6)

Other income, net (Note 6) at other companies

LivaNova logo
LivaNovaLIVN
$98K+234%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$12.02M+4,145%
Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT
Danaher logo
DanaherDHR
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's other income, net (note 6)?
Haemonetics (HAE) reported other income, net (note 6) of -$5.37M in Q1 2026.
How has Haemonetics's other income, net (note 6) changed year-over-year?
Haemonetics's other income, net (note 6) decreased by 798.7% year-over-year, from -$598K to -$5.37M.
What is the long-term trend for Haemonetics's other income, net (note 6)?
Over 4 years (2022 to 2026), Haemonetics's other income, net (note 6) has grown at a 13.8% compound annual growth rate (CAGR), from -$17.12M to -$28.7M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.